EMERYVILLE, Calif. (AP) — EMERYVILLE, Calif. (AP) — Metagenomi Inc. (MGX) on Tuesday reported a loss of $20.4 million in its third quarter.
The Emeryville, California-based company said it had a loss of 55 cents per share.
The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 60 cents per share.
The genetic medicines company posted revenue of $8.7 million in the period.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MGX at https://www.zacks.com/ap/MGX
/AI%20(artificial%20intelligence)/AI%20engineer%20working%20on%20laptop%20by%20ART%20STOCK%20CREATIVE%20via%20Shutterstock.jpg)
/Nike%2C%20Inc_%20swish%20by-%20Tartezy%20via%20Shutterstock.jpg)
